Mainstays Give And Take As Major Japan Firms Report Results
Xtandi Pressures, Enhertu Prospects
Executive Summary
While Daiichi Sankyo reveals ambitious plan with Enhertu, Chugai shows stable growth plans with COVID-19 drugs, Astellas reacted to concerns over Xtandi’s slow growth with enthusiastic investment plan for the next potential star.